Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial

Published:2017-12 Issue:12 Volume:18 Page:1637-1651
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Bang Yung-Jue,Xu Rui-Hua,Chin Keisho,Lee Keun-Wook,Park Se Hoon,Rha Sun Young,Shen Lin,Qin Shukui,Xu Nong,Im Seock-Ah,Locker Gershon,Rowe Phil,Shi Xiaojin,Hodgson Darren,Liu Yu-Zhen,Boku Narikazu

Publisher

Elsevier BV

Subject

Oncology

Reference26 articles.

1. Characteristics of gastric cancer in Asia;Rahman;World J Gastroenterol,2014

2. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial;Wilke;Lancet Oncol,2014

3. Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial;Hironaka;J Clin Oncol,2013

4. Targeting the DNA damage response in cancer;O'Connor;Mol Cell,2015

5. Randomized, double-blind phase II trial with prospective classification by ATM protein level to evaluate the efficacy and tolerability of olaparib plus paclitaxel in patients with recurrent or metastatic gastric cancer;Bang;J Clin Oncol,2015

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with hereditary gastric cancer linked to a family history of hereditary breast and ovarian cancer (HBOC);2024-09-05

2. Unveiling promising targets in gastric cancer therapy: A comprehensive review;Molecular Therapy: Oncology;2024-09

3. Neurological toxicities with poly (ADP-ribose) polymerase inhibitors in cancer patients: a systematic review and meta-analysis;Journal of Chemotherapy;2024-08-23

4. Landscape of homologous recombination deficiency in gastric cancer and clinical implications for first-line chemotherapy;Gastric Cancer;2024-08-07

5. Emerging Therapeutic Targets and Future Directions in Advanced Gastric Cancer: A Comprehensive Review;Cancers;2024-07-29